Loading...

ACHV ACHIEVE LIFE SCIENCES INC Management Changes 8-K Filing

CHV

CHV

ACHIEVE LIFE SCIENCES INC

(ACHV)

2026 8-K

Management Changes

Stock Issuance Agreement

Financial Results

Third Quarter Results

Management Change

Management Change

Earnings Releases

Equity Offerings

Financial Statements

Financial Results

Management Change

Q3 Financial Results

Q2 Financial Results

Refinancing of Term Loans

Financial Results Announcement

Financial Results Announcement

Securities Purchase Agreeme...

FDA Update on Cytisinicline...

Earnings Reports

Earnings Reports

Securities Purchase Agreement

Debt Agreement and Converti...

Earnings Reports

External Links:

Achieve Life Sciences, Inc. reported the resignation of Thomas King as chairman effective June 8, 2026, and the departure of Chief Commercial Officer Jaime Xinos on May 31, 2026. Additionally, Christopher Martin was appointed as a director effective May 11, 2026, with a compensation package including 47,250 stock options.

AI Assistant

ACHIEVE LIFE SCIENCES INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.